Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites
Authors
Keywords
-
Journal
CLINICAL PHARMACOKINETICS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-02-16
DOI
10.1007/s40262-018-0637-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach
- (2016) N Marsousi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- High On-Treatment Platelet Reactivity in Peripheral Arterial Disease: A Pilot Study to Find the Optimal Test and Cut Off Values
- (2016) T.C. Leunissen et al. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Experimental design and analysis and their reporting: new guidance for publication in BJP
- (2015) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetic Interaction Between Prasugrel and Ritonavir in Healthy Volunteers
- (2013) Virginie Ancrenaz et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial
- (2013) TN Kakuda et al. HIV MEDICINE
- Time-Dependent Interaction of Ritonavir in Chronic Use: The Power Balance Between Inhibition and Induction of P-Glycoprotein and Cytochrome P450 3A
- (2013) Keizo Fukushima et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- HIV and Coronary Heart Disease
- (2013) Franck Boccara et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization
- (2012) Paul A. Gurbel JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON-TIMI 38 Substudy
- (2011) Jeffrey S. Riesmeyer et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug–drug interaction in HIV patients
- (2011) Youssef Daali et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Clopidogrel response: Head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting
- (2010) Thomas Cuisset et al. Archives of Cardiovascular Diseases
- A Phenotype–Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir
- (2010) J B Dumond et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dose-Related Reduction in Bupropion Plasma Concentrations by Ritonavir
- (2010) Joohyun Park et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer
- (2010) Lianhong Xu et al. ACS Medicinal Chemistry Letters
- Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
- (2009) Priscilla Y Hsue et al. AIDS
- Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay
- (2009) Rossella Marcucci et al. CIRCULATION
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors
- (2008) Franck Boccara AIDS
- Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
- (2008) Matthew J. Price et al. EUROPEAN HEART JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now